BTLA and neoplasm: Simultaneous up-regulation of iICPs (for example, BTLA) and corresponding ligands at the CAFs (for example, HVEM) leads to inhibition of CTLs in the tumor medium, which eventually leads to more inhibition of immune cells in the TME (20).